FDA inspection
Amorepacific Corporation: FDA inspection ending Mar 16, 2024
FDA inspection 1233111 · Voluntary Action Indicated (VAI) · Osan
Key facts
| Inspection ID | 1233111 |
|---|---|
| Firm | Amorepacific Corporation |
| FEI number | 3010387507 |
| Address | 37 Gajangsaneopdong Ro |
| City | Osan |
| Country | Korea (the Republic of) |
| Fiscal year | 2024 |
| Inspection end date | Mar 16, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data